Matched Placebos

DRUG3 trials

Sponsors

Vertex Pharmaceuticals Incorporated, Gateway Institute for Brain Research, University of Florida

Conditions

Cystic FibrosisParkinson DiseasePlantar Fasciitis

Phase 1

A Study Evaluating Safety and Pharmacokinetics of VX-440 in Combination With Tezacaftor/Ivacaftor in Healthy Adult Subjects

CompletedNCT03486236

Vertex Pharmaceuticals IncorporatedCystic Fibrosis

Start: 2016-07-20End: 2016-09-14Updated: 2018-04-03

Phase 2

Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease

RecruitingNCT05266417

Gateway Institute for Brain ResearchParkinson Disease

Start: 2022-02-07End: 2027-11-30Target: 56Updated: 2026-07-22

A Double-Blinded Study on Rapid and Sustained Pain Relief Topical Cannabidiol for Plantar Fasciitis

Not yet recruitingNCT07776405

University of FloridaPlantar Fasciitis

Start: 2026-09-01End: 2027-03-31Target: 50Updated: 2026-09-03